Package 62332-586-31

{"route": ["ORAL"], "spl_id": "a9507ffa-0c95-48ce-80bf-60bc699add17", "openfda": {"unii": ["M6Q1EO9TD0"], "rxcui": ["849395"], "spl_set_id": ["da1837b5-fda2-48e0-91ba-d6eb2b991b55"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (62332-586-31)", "package_ndc": "62332-586-31", "marketing_start_date": "20201020"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (62332-586-71)", "package_ndc": "62332-586-71", "marketing_start_date": "20201020"}], "brand_name": "Amantadine", "product_id": "62332-586_a9507ffa-0c95-48ce-80bf-60bc699add17", "dosage_form": "TABLET", "pharm_class": ["Influenza A M2 Protein Inhibitor [EPC]", "M2 Protein Inhibitors [MoA]"], "product_ndc": "62332-586", "generic_name": "Amantadine", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amantadine", "active_ingredients": [{"name": "AMANTADINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA214284", "marketing_category": "ANDA", "marketing_start_date": "20201020", "listing_expiration_date": "20261231"}